MARKET

CBMG

CBMG

Cellular
NASDAQ

Real-time Quotes | Nasdaq Last Sale

17.48
-0.16
-0.91%
After Hours: 17.48 0 0.00% 16:00 01/17 EST
OPEN
17.84
PREV CLOSE
17.64
HIGH
17.91
LOW
17.46
VOLUME
58.48K
TURNOVER
--
52 WEEK HIGH
20.50
52 WEEK LOW
10.98
MARKET CAP
355.48M
P/E (TTM)
-7.2441
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CBMG and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CBMG News

  • Cellular Biomedicine Group Announces Engagement Of Independent Advisors By Special Committee Formed To Evaluate Strategic Alternatives Including $19.50/Share Preliminary Non-Binding Proposal
  • Benzinga.12/30/2019 13:31
  • Cellular Biomedicine Group Announces Engagement of Independent Advisors by Special Committee
  • PR Newswire.12/30/2019 13:30
  • Cellular Biomedicine Group (CBMG) Presents At 2019 ASH Annual Meeting - Slideshow
  • Seeking Alpha - Article.12/11/2019 13:53
  • China’s Curing Cancer Faster and Cheaper Than Anywhere Else
  • Bloomberg.12/10/2019 21:00

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About CBMG

Cellular Biomedicine Group Inc. is engaged in the development of cell therapy technologies. The Company develops cell therapies for the treatment of cancer and degenerative diseases. The Company conducts immuno-oncology and stem cell clinical trials in China using products from the goods manufacturing practices (GMP) laboratory. The Company's technology includes platforms, such as Immune Cell therapy for treatment of broad range of cancers using Vaccine, T Cells Receptor (TCR) clonality analysis technology and T Central Memory Cell (Tcm) preparation methodologies, Chimeric Antigen Receptor T cell (CAR-T), and human adipose-derived mesenchymal progenitor cells (haMPC) for treatment of joint and autoimmune diseases, with primary research and manufacturing facilities in China. The Company is focused on developing and marketing cell-based therapies based on its cellular platforms, to treat serious chronic and degenerative diseases, such as cancer, orthopedic diseases.
More

Webull offers Cellular Biomedicine Group Inc (CBMG) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.